e-Edition
Obituaries
Special Sections
Special Occasions
Contact

Subscribe
Paywall Login
Login to Comment
Register

December 11th, 2017

jobs

homes

Home
News
Sports
Business
Entertainment
Classifieds
Commentary

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Aquestive Therapeutics, Inc. - Common Stock (NQ:AQST)

3.910 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Jan 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Aquestive Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

September 06, 2022

Gainers Metacrine (NASDAQ:MTCR) shares rose 13.8% to $0.54 during Tuesday's after-market session. This security traded at a volume of 3.0 million shares come close, making up 948.6% of its average...

Via Benzinga

Where Aquestive Therapeutics Stands With Analysts ↗

September 06, 2022

Aquestive Therapeutics (NASDAQ:AQST) has observed the following analyst ratings within the last quarter:

Via Benzinga

FedEx Faces Price Target Cut By This Analyst; Also Check Out Some Other Major PT Changes ↗

September 06, 2022

Citigroup cut the price target on FedEx Corporation (NYSE: FDX) from $270 to $225. Citigroup analyst Christian Wetherbee also downgraded the stock from Buy to Neutral. FedEx shares fell 3% to trade at...

Via Benzinga

Aquestive Gets FDA Tentative Approval For Libervant In Seizure Clusters Management ↗

August 31, 2022

The U.S.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

August 30, 2022

Via Benzinga

Aquestive Therapeutics Reveals Favorable Data From Epinephrine Trial For Allergies ↗

June 16, 2022

Via Benzinga

Why Nuwellis Surged Over 121%; Here Are 66 Biggest Movers From Yesterday ↗

September 01, 2022

Gainers

Via Benzinga

NASDAQ:AQST Investor Notice: Update in Lawsuit Against Aquestive Therapeutics, Inc. Announced ↗

August 25, 2022

San Diego, CA -- (SBWIRE) -- 08/25/2022 -- The Shareholders Foundation announced an update in the lawsuit that is pending for certain investors in shares of Aquestive Therapeutics, Inc. (NASDAQ:AQST).

Via SBWire

Why Express Is Trading Higher By Over 21%, Here Are 54 Stocks Moving In Wednesday's Mid-Day Session ↗

August 31, 2022

Gainers Nuwellis, Inc. (NASDAQ: NUWE) shares jumped 140% to $1.5894 after the company announced new clinical data demonstrating 100% survival at 30 days following the use of ultrafiltration in...

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

August 12, 2022

Via Benzinga

Why Embark Technology Jumped Around 85%; Here Are 108 Biggest Movers From Friday ↗

August 15, 2022

Gainers Embark Technology, Inc. (NASDAQ: EMBK) jumped 84.8% to close at $1.07 on Friday after the company reported better-than-expected Q2 EPS results.

Via Benzinga

Aquestive Therapeutics: Q2 Earnings Insights ↗

August 02, 2022

Aquestive Therapeutics (NASDAQ:AQST) reported its Q2 earnings results on Tuesday, August 2, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Aquestive Therapeutics...

Via Benzinga

Earnings Preview: Aquestive Therapeutics ↗

August 01, 2022

Aquestive Therapeutics (NASDAQ:AQST) is set to give its latest quarterly earnings report on Tuesday, 2022-08-02. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

63 Biggest Movers From Yesterday ↗

June 17, 2022

Gainers Advent Technologies Holdings, Inc. (NYSE: ADN) shares surged 244% to close at $3.99 on Thursday after the company announced it received notification of euro 782.1 million of funding from the...

Via Benzinga

The Daily Biotech Pulse: Roche's Alzheimer's Drug Fails, Advisors Back Pfizer, Moderna Shots For Youngest Kids, Valneva Settles COVID-19 Pact With UK ↗

June 16, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

June 03, 2022

During Friday's trading, 69 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

June 02, 2022

During the Thursday's session, 100 stocks hit new 52-week lows.

Via Benzinga

The Daily Biotech Pulse: Pfizer/BioNTech's COVID-19 Booster For Kids, Moderna Starts First African Trial Of mRNA HIV Vaccine, Tonix Extends COVID-19 Antiviral Research Pact ↗

May 18, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs ↗

May 03, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

Earnings Outlook For Aquestive Therapeutics ↗

May 02, 2022

Aquestive Therapeutics (NASDAQ:AQST) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

April 29, 2022

Via Benzinga

Aquestive's AQST-109 Receives Fast Track Tag For Allergic Reactions ↗

March 17, 2022

The FDA has granted Fast Track Designation to Aquestive Therapeutics Inc's (NASDAQ: AQST) AQST-109 for allergic reactions. AQST-109 is an orally delivered epinephrine-based product candidate for the...

Via Benzinga

Looking Into Aquestive Therapeutics's Return On Capital Employed ↗

March 11, 2022

Benzinga Pro data, Aquestive Therapeutics (NASDAQ:AQST) reported Q4 sales of $11.08 million. Earnings fell to a loss of $28.95 million, resulting in a 98.87% decrease from last...

Via Benzinga

NASDAQ:AQST Shareholder Notice: Investigation over Potential Wrongdoing at Aquestive Therapeutics, Inc. ↗

March 09, 2022

San Diego, CA -- (SBWIRE) -- 03/09/2022 -- Certain directors of Aquestive Therapeutics, Inc. are under investigation over potential breaches of fiduciary duties.

Via SBWire

The Daily Biotech Pulse: Moderna Outlines Steps For mRNA Tech Advancement, Voyager-Novartis Strike Licensing Deal, Valneva Reports Positive Chikungunya Shot Readout ↗

March 08, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Moderna Announces 4 Initiatives To Advance mRNA Vaccines As Preventative...

Via Benzinga

A Preview Of Aquestive Therapeutics's Earnings ↗

March 07, 2022

Aquestive Therapeutics (NASDAQ:AQST) is set to give its latest quarterly earnings report on Tuesday, 2022-03-08. Here's what investors need to know before the announcement....

Via Benzinga

Week In Review: Adagene Forms $2.5 Billion, Four-Drug Partnership With Sanofi ↗

March 05, 2022

Adagene will apply its technology to as many as four Sanofi candidates in a collaboration worth up to $2.5 billion. Huadong Medicine will acquire Asia rights for two Heidelberg Pharma ADC candidates in...

Via Talk Markets

Earnings Scheduled For March 8, 2022 ↗

March 08, 2022

Companies Reporting Before The Bell • Babcock & Wilcox (NYSE:BW) is likely to report quarterly earnings at $0.10 per share on revenue of $196.62 million. •...

Via Benzinga

The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg ↗

March 06, 2022

Biotech stocks reversed course in the week ending March 4, as the Ukrainian crisis weighed down on the broader market as well as the sector. The iShares Biotechnology ETF (...

Via Benzinga

Aquestive Highlights Early Data From Allergy Treatment Candidate AQST-109 Study ↗

February 25, 2022

Aquestive Therapeutics Inc (NASDAQ: AQST) announced positive topline results from Part 1 of the EPIPHAST study for its AQST-109 epinephrine oral film. Part 1...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

More ways to get to us

Facebook

Twitter

YouTube

ePaper Login
Subscribe
Subscription Services
Archive

About Us

The Lethbridge Herald
Other Publications
Food For Thought

Contact
Careers

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

Advertising
Terms and Conditions & Privacy Policy